Spider Telangiectasias Pediatric Research and Clinical Trials

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the Vascular Anomalies Center

At Boston Children's Hospital, we’re known for our science-driven approach. We’re home to the world's most extensive pediatric hospital research enterprise; and we partner with elite health care and biotech organizations around the globe.

Our Vascular Anomalies Center (VAC) conducts research that may lead to the development of new, more effective therapies for spider telangiectasias and perhaps ultimately result in ways to prevent these anomalies. The VAC has generated an extensive case database on vascular anomalies. As our database grows, it will help shine more light on spider telangiectasias and other vascular anomalies.

Spider telangiectasias: Reviewed by Marilyn Liang, MD
© Boston Children's Hospital, 2015

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close